Neoadjuvant Four-Drug Combination Therapy for NSCLC With EGFR Mutation Avoiding Total Pneumonectomy
An Erratum on
Neoadjuvant Four-Drug Combination Therapy for NSCLC With EGFR Mutation Avoiding Total Pneumonectomy
by Li, J., Xu, K., Cai, W., Zhang, Y., Zeng, X., Cui, F., et al. (2020). Front. Oncol. 10:1145. doi: 10.3389/fonc.2020.01145
Due to an editorial error, the wrong version of the manuscript was typeset and published. The publisher apologizes for this mistake. The original article has been updated.
Keywords: neoadjuvant, EGFR mutation, targeted (selective) treatment, chemothearpy, surgery
Citation: Frontiers Production Office (2020) Erratum: Neoadjuvant Four-Drug Combination Therapy for NSCLC With EGFR Mutation Avoiding Total Pneumonectomy. Front. Oncol. 10:1573. doi: 10.3389/fonc.2020.01573
Received: 20 July 2020; Accepted: 21 July 2020;
Published: 29 July 2020.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2020 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn